Matthew F. Wipperman
Affiliations: | Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States |
Area:
chemistry, chemical biology, tuberculosis, biochemistry, clinical researchGoogle:
"Matthew F. Wipperman, Matthew Wipperman"Bio:
https://www.grad.stonybrook.edu/pdf/academics/ddd/Matthew%20F.%20Wipperman.pdf
Mean distance: 8.45 | S | N | B | C | P |
Parents
Sign in to add mentor| Nicole S. Sampson | grad student | 2015 | SUNY Stony Brook | |
| (Mycobacterium tuberculosis cholesterol catabolism utilizes an evolutionary discrete class of acyl-Coenzyme A dehydrogenase) | ||||
| Michael Glickman | post-doc | Memorial Sloan Kettering Cancer Center (Microtree) | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yang X, Wipperman MF, Nachman S, et al. (2022) Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children. Bmc Infectious Diseases. 22: 158 |
| de Araujo LS, Ribeiro-Alves M, Wipperman MF, et al. (2021) Transcriptomic Biomarkers for Tuberculosis: Validation of as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response. Cells. 10 |
| Wipperman MF, Bhattarai SK, Vorkas CK, et al. (2021) Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis. Nature Communications. 12: 1141 |
| Gadbery J, Round J, Yuan T, et al. (2020) IpdE1-IpdE2 is a heterotetrameric acyl coenzyme A dehydrogenase that is widely distributed in steroid-degrading bacteria. Biochemistry |
| Wipperman MF, Montrose DC, Gotto AM, et al. (2019) Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health. The American Journal of Pathology. 189: 492-501 |
| Vorkas CK, Wipperman MF, Li K, et al. (2018) Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection. Jci Insight. 3 |
| Namasivayam S, Sher A, Glickman MS, et al. (2018) The Microbiome and Tuberculosis: Early Evidence for Cross Talk. Mbio. 9 |
| Wipperman MF, Heaton BE, Nautiyal A, et al. (2018) Mycobacterial Mutagenesis and Drug Resistance Are Controlled by Phosphorylation- and Cardiolipin-Mediated Inhibition of the RecA Coprotease. Molecular Cell |
| Wipperman MF, Fitzgerald DW, Juste MAJ, et al. (2017) Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Scientific Reports. 7: 10767 |
| Namasivayam S, Maiga M, Yuan W, et al. (2017) Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome. 5: 71 |